Medicared For All Logo

Beaula Koduri MD in Edison, New Jersey

Home New Jersey Edison

Beaula Koduri MD has Hematology/oncology as her primary medical specialty. Their primary office is: 2110 Oak Tree Rd in Edison, New Jersey. They attended Sorry, her university is not listed and graduated in 1995 (around 29 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Beaula V Koduri MD Office Phone and Directions

Beaula Koduri MD
2110 Oak Tree Rd
Edison, New Jersey 08820
732-483-4501


Patient Ratings
Please rate your experience with Beaula Koduri MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 732-483-4501


Enter a starting address:


Healthcare Info for Beaula Koduri MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, her university is not listed
Graduation Year: 1995
The Primary Medical Specialty for Beaula Koduri MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 29
PAC (PECOS ID)#: 9032189105
NPI #: 1972505311
NPI Created On: 08/15/2005
NPI Last Updated Listed as: 09/23/2014
Primary Taxonomy Code: 207RH0003X
License Number:
25MA08158600
Listed Gender: Female

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • AmeriHealth New Jersey
  • Blue Cross Blue Shield
  • Humana
  • Oscar Garden State Insurance Corporation
  • Medicare

They are listed as accepting new patients in some locations.

Languages spoken by staff include: English, Spanish, Hindi, Gujarati, Arabic.


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Complete blood cell count (red cells, white blood cell, platelets), automated test
  3. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  4. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  5. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  6. Infusion of chemotherapy into a vein up to 1 hour
  7. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
  8. New patient office or other outpatient visit, typically 20 minutes
  9. New patient office or other outpatient visit, typically 30 minutes
  10. New patient office or other outpatient visit, typically 45 minutes
  11. New patient office or other outpatient visit, typically 60 minutes
  12. Established patient office or other outpatient visit, typically 10 minutes
  13. Established patient office or other outpatient visit, typically 15 minutes
  14. Established patient office or other outpatient, visit typically 25 minutes
  15. Established patient office or other outpatient, visit typically 40 minutes
  16. Initial hospital inpatient care, typically 70 minutes per day
  17. Subsequent hospital inpatient care, typically 35 minutes per day
  18. Injection, epoetin alfa, (for non-esrd use), 1000 units
  19. Injection, dexamethasone sodium phosphate, 1 mg
  20. Injection, diphenhydramine hcl, up to 50 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $99

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788875947

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788875949

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788875951

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788875953

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788875955

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788875957

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788875959

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788875961

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788875963

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788875967

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Hematology/oncology Professionals in Edison

65 James St
Edison, NJ
Hackensack Meridian Health Medical Group - Specialty Care Pc

2177 Oak Tree Rd
Edison, NJ
Regional Cancer Care Associates Llc

15 Main St
Edison, NJ
Regional Cancer Care Associates Llc

2177 Oak Tree Rd
Edison, NJ
Regional Cancer Care Associates Llc

15 Main St
Edison, NJ
Regional Cancer Care Associates Llc

35 -37 Progress St
Edison, NJ

Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry